CY1108302T1 - Φαρμακευτικη συνθεση με βαση αζαλιδες για τοπικη εφαρμογη στην οφθαλμολογια - Google Patents
Φαρμακευτικη συνθεση με βαση αζαλιδες για τοπικη εφαρμογη στην οφθαλμολογιαInfo
- Publication number
- CY1108302T1 CY1108302T1 CY20081100927T CY081100927T CY1108302T1 CY 1108302 T1 CY1108302 T1 CY 1108302T1 CY 20081100927 T CY20081100927 T CY 20081100927T CY 081100927 T CY081100927 T CY 081100927T CY 1108302 T1 CY1108302 T1 CY 1108302T1
- Authority
- CY
- Cyprus
- Prior art keywords
- pharmaceutical composition
- composition
- carrier
- carbon atoms
- solution
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Η εφεύρεση αφορά σε μια φαρμακευτική σύνθεση για την πρόληψη και/ή θεραπεία οφθαλμικών λοιμώξεων η οποία χρησιμοποιείται για τοπική εφαρμογή. Στοχεύει ειδικότερα σε μια σύνθεση που παρουσιάζεται υπό μορφή κολλυρίου που παρέχεται σταγόνα-σταγόνα στην οποία ένας αντιβιοτικός παράγοντας της κατηγορίας των μακρολιδίων, τέτοιος όπως η αζιθρομυκίνη, είναι σε διάλυμα μέσα σε ένα ελαιώδη φορέα. Αυτός ο φορέας είναι κυρίως του τύπου των προϊόντων που αποτελούνται ουσιαστικά από τριγλυκερίδια μεσαίας αλυσίδας στα οποία οι λειτουργίες γλυκερόλης εστεροποιούνται πλήρως από καρβοξυλικά οξέα κορεσμένων υδρογονανθράκων των οποίων το μόριο φέρει 5 έως 12 άτομα άνθρακα. Πρόκειται κατά προτίμηση για λιπαρά οξέα γραμμικής αλυσίδας που περιέχουν 8 έως 10 άτομα άνθρακα, όπως το παπρυλικό οξύ και το καπρικό οξύ. Η σύνθεση παρασκευάζεται πλεονεκτικά με την τοποθέτηση σε διάλυμα του δραστικού παράγοντα μέσα σε ένα ελαιώδες φορέα που γίνεται σε μια θερμοκρασία που δεν υπερβαίνει τους 70 °C.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0105114A FR2823441B1 (fr) | 2001-04-12 | 2001-04-12 | Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation |
EP02732804A EP1377316B1 (fr) | 2001-04-12 | 2002-04-11 | Composition pharmaceutique a base de azalides pour application locale en ophtalmologie |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1108302T1 true CY1108302T1 (el) | 2014-02-12 |
Family
ID=8862340
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20081100927T CY1108302T1 (el) | 2001-04-12 | 2008-08-28 | Φαρμακευτικη συνθεση με βαση αζαλιδες για τοπικη εφαρμογη στην οφθαλμολογια |
Country Status (31)
Country | Link |
---|---|
US (1) | US7064109B2 (el) |
EP (1) | EP1377316B1 (el) |
JP (2) | JP4558275B2 (el) |
KR (1) | KR100835002B1 (el) |
CN (1) | CN1496270B (el) |
AR (1) | AR034033A1 (el) |
AT (1) | ATE397460T1 (el) |
BR (1) | BRPI0208367B8 (el) |
CA (1) | CA2443728C (el) |
CY (1) | CY1108302T1 (el) |
CZ (1) | CZ300213B6 (el) |
DE (1) | DE60226962D1 (el) |
DK (1) | DK1377316T3 (el) |
EA (1) | EA008088B1 (el) |
EG (1) | EG23169A (el) |
ES (1) | ES2307754T3 (el) |
FR (1) | FR2823441B1 (el) |
HK (1) | HK1065708A1 (el) |
HR (1) | HRP20030907B1 (el) |
HU (1) | HU230459B1 (el) |
MA (1) | MA27005A1 (el) |
MX (1) | MXPA03009349A (el) |
OA (1) | OA12462A (el) |
PA (1) | PA8543401A1 (el) |
PE (1) | PE20021082A1 (el) |
PL (1) | PL204403B1 (el) |
PT (1) | PT1377316E (el) |
SI (1) | SI1377316T1 (el) |
TN (1) | TNSN03091A1 (el) |
WO (1) | WO2002083178A1 (el) |
ZA (1) | ZA200307718B (el) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1655021B1 (en) * | 2004-11-09 | 2008-10-29 | Novagali Pharma SA | Oil-in-water type emulsion with low concentration of cationic agent and positive zeta potential |
FR2884716B1 (fr) * | 2005-04-22 | 2009-08-21 | Thea Sa Lab | Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires |
JPWO2007074904A1 (ja) * | 2005-12-28 | 2009-06-04 | わかもと製薬株式会社 | 水性医薬組成物 |
WO2008106228A2 (en) * | 2007-02-28 | 2008-09-04 | Aciex Therapeutics, Inc. | Methods and compositions for normalizing meibomian gland secretions |
US20100158821A1 (en) * | 2008-12-22 | 2010-06-24 | Eastman Chemical Company | Antimicrobial agents, compositions and products containing the same, and methods of using the compositions and products |
CN101780105B (zh) * | 2009-01-20 | 2011-09-28 | 沈阳兴齐制药有限公司 | 小牛血去蛋白提取物的滴眼液 |
EP2228058A1 (en) | 2009-03-04 | 2010-09-15 | Novagali Pharma S.A. | Anionic oil-in-water emulsion containing prostaglandins and uses thereof |
US8106111B2 (en) * | 2009-05-15 | 2012-01-31 | Eastman Chemical Company | Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions |
EP2389939A1 (en) | 2010-05-28 | 2011-11-30 | Novagali Pharma S.A. | Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions |
EP2394636B1 (en) * | 2010-05-28 | 2014-03-19 | Novagali Pharma S.A. | Method for treating retinal conditions using an intraocular tamponade |
US9044508B2 (en) * | 2013-03-15 | 2015-06-02 | Insite Vision Corporation | Concentrated aqueous azalide formulations |
KR20190024983A (ko) * | 2016-06-29 | 2019-03-08 | 오토노미, 인코포레이티드 | 트리글리세라이드 귀 제제 및 이의 용도 |
EP3266446B1 (en) * | 2016-07-07 | 2018-11-21 | Laboratorios SALVAT, S.A. | Ophthalmic composition comprising castor oil and medium chain triglyceride |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1152644A (en) * | 1966-07-01 | 1969-05-21 | Abbott Lab | Stable Solutions of Erythromycin Free Base |
JPS6468328A (en) * | 1987-09-09 | 1989-03-14 | Suntory Ltd | Anticorneoulcerative |
JP2563336B2 (ja) * | 1987-06-01 | 1996-12-11 | エーザイ株式会社 | 角膜透過促進点眼剤 |
FR2746035B1 (fr) * | 1996-03-15 | 1998-06-12 | Microparticules de gel composite susceptibles d'etre utilisees comme vecteur(s) de principe(s) actif(s), l'un de leurs procedes de preparation et leurs applications | |
DK0925789T4 (da) * | 1997-12-02 | 2009-07-13 | Pfizer Prod Inc | Anvendelse af azithromycin ved topisk behandling af öjeninfektioner |
JP2000159659A (ja) * | 1998-11-30 | 2000-06-13 | Kazuo Tsubota | 眼科用人工涙液 |
US6239113B1 (en) * | 1999-03-31 | 2001-05-29 | Insite Vision, Incorporated | Topical treatment or prevention of ocular infections |
-
2001
- 2001-04-12 FR FR0105114A patent/FR2823441B1/fr not_active Expired - Lifetime
-
2002
- 2002-04-09 PA PA20028543401A patent/PA8543401A1/es unknown
- 2002-04-10 AR ARP020101319A patent/AR034033A1/es not_active Application Discontinuation
- 2002-04-10 EG EG20020380A patent/EG23169A/xx active
- 2002-04-11 DK DK02732804T patent/DK1377316T3/da active
- 2002-04-11 SI SI200230723T patent/SI1377316T1/sl unknown
- 2002-04-11 DE DE60226962T patent/DE60226962D1/de not_active Expired - Lifetime
- 2002-04-11 CZ CZ20032771A patent/CZ300213B6/cs not_active IP Right Cessation
- 2002-04-11 AT AT02732804T patent/ATE397460T1/de active
- 2002-04-11 KR KR1020037012372A patent/KR100835002B1/ko active IP Right Grant
- 2002-04-11 PE PE2002000306A patent/PE20021082A1/es not_active Application Discontinuation
- 2002-04-11 CN CN02806447XA patent/CN1496270B/zh not_active Expired - Lifetime
- 2002-04-11 CA CA2443728A patent/CA2443728C/fr not_active Expired - Lifetime
- 2002-04-11 EA EA200301108A patent/EA008088B1/ru not_active IP Right Cessation
- 2002-04-11 PL PL363538A patent/PL204403B1/pl unknown
- 2002-04-11 US US10/474,811 patent/US7064109B2/en not_active Expired - Lifetime
- 2002-04-11 MX MXPA03009349A patent/MXPA03009349A/es active IP Right Grant
- 2002-04-11 HU HU0303864A patent/HU230459B1/hu unknown
- 2002-04-11 EP EP02732804A patent/EP1377316B1/fr not_active Expired - Lifetime
- 2002-04-11 JP JP2002580979A patent/JP4558275B2/ja not_active Expired - Lifetime
- 2002-04-11 WO PCT/FR2002/001263 patent/WO2002083178A1/fr active IP Right Grant
- 2002-04-11 ES ES02732804T patent/ES2307754T3/es not_active Expired - Lifetime
- 2002-04-11 PT PT02732804T patent/PT1377316E/pt unknown
- 2002-04-11 BR BRPI0208367A patent/BRPI0208367B8/pt not_active IP Right Cessation
- 2002-04-11 OA OA1200300246A patent/OA12462A/fr unknown
- 2002-04-11 TN TNPCT/FR2002/001263A patent/TNSN03091A1/fr unknown
-
2003
- 2003-09-26 MA MA27325A patent/MA27005A1/fr unknown
- 2003-10-02 ZA ZA200307718A patent/ZA200307718B/en unknown
- 2003-11-10 HR HR20030907A patent/HRP20030907B1/xx not_active IP Right Cessation
-
2004
- 2004-11-01 HK HK04108553.8A patent/HK1065708A1/xx not_active IP Right Cessation
-
2008
- 2008-08-28 CY CY20081100927T patent/CY1108302T1/el unknown
-
2009
- 2009-10-08 JP JP2009234250A patent/JP5170780B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1108302T1 (el) | Φαρμακευτικη συνθεση με βαση αζαλιδες για τοπικη εφαρμογη στην οφθαλμολογια | |
DK1041072T3 (da) | Dioxocyclopentylhydroxamsyrer | |
AR031430A1 (es) | Compuestos de bisarilo orto, meta-sustituidos, procedimientos para su preparacion, su utilizacion como medicamento como tambien los preparados farmaceuticos que los contienen | |
AR026593A1 (es) | Formulaciones para agentes farmaceuticos ionizables como acidos libres o bases libres | |
ATE260255T1 (de) | 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate | |
BR9205526A (pt) | Misturas de oleos microbianos e usos dos mesmos | |
PA8451801A1 (es) | Derivados de la 9-oxima eritromicina | |
FI902877A0 (fi) | N-substituerade lauramider, deras framstaellning och sammansaettningar, daer de aer naervarande. | |
EA200200232A1 (ru) | Интерлейкин-5 ингибирующие производные 6-азаурацила | |
AR004625A1 (es) | Composicion de un oseo activo que comprende una sustancia de un oseo activo y un carrier bilogico de dicha sustancia,composicion farmaceutica que comprende dicha composicion de un oseo-activo,y uso de dicha composicion para la preparacion de un medicamento | |
ES2096401T3 (es) | Derivados de 9a-n-(n'-carbamoil) y de 9a-n-(n'-tiocarbamoil) de 9-desoxo-9a-aza-9a-homoeritromicina a. | |
BRPI0408423A (pt) | composições farmacêuticas compreendendo uma combinação de rapamicina ou seus derivados e pimecrolimus para o tratamento de doenças mediadas imunologicamente e por inflamação | |
ES2164869T3 (es) | Conjugados lipidos especificos de nucleosidos-difosfato y su uso como medicamentos. | |
RU2010104872A (ru) | Гидрогель карбоксиалкиламида хитозана, его приготовление и применение в косметологии и дерматологии | |
EE200200143A (et) | 4-bensüülaminokinoliini konjugaadid sapphappega ja nende heteroanaloogid, nende valmistamismeetod ning neid ühendeid sisaldavad ravimid ja nende kasutamine | |
AR014320A1 (es) | Compuestos de (2r,3s,4s,5r,6r,10r,11r)-2,4,6,8,10-pentametil-11-acetil-12, 13-dioxabiciclo[8.2.1]tridec-8-en-1-ona, medicamentos que contienen estoscompuestos y procedimiento para la preparacion de dichos compuestos | |
PT838470E (pt) | Derivados 9-n-etenilo de 9(s)-eritromicilamina | |
ES2049703T3 (es) | Derivados sulfurados de acidos biliares. | |
PT90706A (pt) | Processo para a preparacao de derivados de antraciclinas dotados de actividade citostatica | |
DE69812059D1 (de) | Beta,beta-disubstituierte Derivate von 9-Deoxo-9a-N-ethenyl-9a-aza-9a-homoerythromycin A | |
CY1115042T1 (el) | Οξυγονωμενοι εστερες 4-ιωδοφαινυλαμινοβενζυδροξαμικων οξεων | |
KR910000155A (ko) | 인간 및 수의학에서의 서맥 및 부정서맥을 치료하기위한 11위치-치환된 5,11-디하이드로-6H-피리도 [2.3-b] [1.4]-벤조디아제핀-6-온의 용도 | |
ECSP982529A (es) | Derivados de la 9-oxima eritromicina | |
TH31604A (th) | อนุพันธ์ของไอโซอินโดล วิธีการเตรียมและการใช้อนุพันธ์ของไอโซอินโดลให้เป็นประโยชน์ในการบำบัดรักษาโรค |